National Comprehensive Cancer Network



About NCCN

Myeloid Growth Factors Panel - Disclosures as of 5/20/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

James Armitage, MD

None

None

None

None

10/8/2012

Lodovico Balducci, MD

None

None

None

None

3/4/2013

Pamela Sue Becker, MD, PhD

Amgen Inc.;
Genzyme Corporation;
sanofi-aventis U.S.

Caremark;
McKesson

None

None

11/26/2012

Douglas W. Blayney, MD

None

Bristol-Myers Squibb Company;
Millennium Pharmaceuticals, Inc.;
National Oncology Consultants;
Seattle Genetics;
UnitedHealthcare

None

American Society of Clinical Oncology

10/17/2011

Spero R. Cataland, MD

None

Amgen Inc.;
Bayer HealthCare;
GlaxoSmithKline

None

None

8/16/2012

Jeffrey Crawford, MD

Amgen Inc.;
Facet Biotech;
Hoffman LaRoche

Amgen Inc.;
Boehringer Ingelheim GmbH;
Aggenix AG

None

None

11/26/2012

Mary Dwyer, MS

None

None

None

None

3/26/2013

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Maria Ho, PhD

None

None

None

None

8/3/2012

Susan Hudock, BS, PharmD, BCOP

None

None

None

None

10/4/2012

Dwight D. Kloth, PharmD, FCCP, BCOP

None

Amgen Inc.;
Eisai Inc.

None

None

5/1/2013

David J. Kuter, MD, PhD

None

caremark

None

None

10/4/2012

Gary H. Lyman, MD, MPH, FRCP

Amgen Inc.

None

None

None

8/9/2012

Joan S. McClure, MS

None

None

None

None

7/23/2012

Brandon McMahon, MD

None

None

None

None

3/11/2013

Hope S. Rugo, MD

None

None

None

None

9/17/2012

Ayman A. Saad, MD

None

None

None

None

8/29/2012

Lee S. Schwartzberg, MD, FACP

Bristol-Myers Squibb Company;
Eisai Inc.

Amgen Inc.;
Eisai Inc.;
Genentech, Inc.;
GlaxoSmithKline

None

None

6/6/2012

Sepideh Shayani, PharmD, BCOP

None

Genzyme Corporation

None

None

4/9/2012

David Steensma, MD

Amgen Inc.

Celgene Corporation;
Jannsen Pharmaceutica Products, LP;
Array Pharmaceuticals

None

None

10/3/2012

Mahsa Talbott, PharmD

None

None

None

None

12/12/2012

Saroj Vadhan-Raj, MD

Amgen Inc.

Amgen Inc.;
Hospira

None

None

4/9/2013

Peter Westervelt, MD, PhD

None

Celgene Corporation;
Novartis Pharmaceuticals Corporation

None

None

11/5/2012

Michael Westmoreland, PharmD

None

Merck & Co., Inc.

None

None

11/5/2012

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved